Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Smitha Menon MD
Associate Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Clinical Cancer Center
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
08/1993 - 12/1997 M.B.B.S, Stanley Medical College, Chennai, India.

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
01/1998 - 01/1999 House Surgeon, Stanley Medical College, India
06/2001 - 06/2002 PGY-1, Internal Medicine, University of Connecticut, Farmington, CT
07/2002 - 06/2004 PGY-2 & PGY-3, Internal Medicine, Mayo Clinic, Rochester, MN
07/2004 - 09/2009 Hematology/Oncology Fellowship, Mayo Clinic, Rochester, MN

FACULTY APPOINTMENTS:
01/2011 - Present Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
01/2011 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
ABIM -Hematology/Oncology
11/2007
12/2017
 
Licensure
Number Issue DateExpiration
Wisconsin
12/23/2010
10/31/2011
 

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2004 - Present American Society of Hematology
2004 - Present American Society of Clinical Oncology

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
A Phase 3 Multicenter Randomized Open-label Study of Oral LDK378 Vs Standard Chemotherapy in Adult Patients w ALK-rearranged Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Been Treated Previously w Chemotherapy
Source:
Novartis Pharmaceutical Corporation
Role:
Site Principal Investigator
Dates:
04/05/2013 - 12/31/2018
 
Title:
Phase III, Randomized, Open-label, Cross-over, Multi-center, Safety & Efficacy Study to Evaluate NAB-Paclitaxel as a Maintenance Treatment
Source:
Celgene corporation
Role:
Site Principal Investigator
Dates:
05/14/2014 - 05/13/2016
 
Title:
A Randomized Open-Label Phase III Trial of MK-3475 vs Platinum Based Chemotherapy in 1L Subjects w PD-L1 Strong Metastatic Non-Small Cell Lung Cancer
Source:
Merck Sharp & Dohme Corp
Role:
Site Principal Investigator
Dates:
01/15/2015 - 01/14/2018
 
Title:
A Phase III,OpenLabel,Randomized Study of AZD9291 vs Platinum-Based Doublet Chemotherapy for pts w/ Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed w/ Previous Epidermal Growth..
Source:
Astra Zeneca
Role:
Site PI
Dates:
02/18/2015 - 02/17/2018
 
Prior
Non-Peer Review
Title:
Impact of Medical Scribes in Enhancing Patient Care in an Academic Hematology/Oncology Practice.
Source:
Froedtert Hospital Foundation
Role:
Principal Investigator
Dates:
10/04/2014 - 06/04/2015
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
Outpatient oncology clinic
 
Resident and Fellow Education
04/13/2011 Didactic Lecture "Prostate Cancer for the primary Physician"
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. S. L. Wolf, R. Qin, S. P. Menon, K. M. Rowland, J. W. Kugler, P. J. Flynn, D. Christian, D. Satele, J. L. Berenberg, C. L. Loprinzi. Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5. JCO 2010 Dec10; 28(35):5182-7
2. Menon SP, Rajkumar SV, Lacy M, Falco P, Palumbo A. Thromboembolic events with lenalidomide based therapy for multiple myeloma. Cancer. 2008 Apr 1;112(7):1522-8.
3. Sargent DJ, Patiyil S et al: Endpoints for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized Trials from the ACCENT group. J Clin Oncol. 2007 Oct 10;25(29):4569-74.
4. Thompson JR, Menon SP. Liquid Biopsies and Cancer Immunotherapy. Cancer J. 2018 Mar/Apr;24(2):78-83.
5. Menon S, Shin S, Dy G. Advances in Cancer Immunotherapy in Solid Tumors. Cancers (Basel). 2016 Nov 24;8(12). PMCID: PMC5187504
6. Desai A, Menon SP, Dy GK. Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options. Cancer Biol Med. 2016 Mar;13(1):77-86. PMCID: PMC4850130
7. Lin JJ, Zhu VW, Schoenfeld AJ, Yeap BY, Saxena A, Ferris LA, Dagogo-Jack I, Farago AF, Taber A, Traynor A, Menon S, Gainor JF, Lennerz JK, Plodkowski AJ, Digumarthy SR, Ou SI, Shaw AT, Riely GJ. Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC. J Thorac Oncol. 2018 10;13(10):1530-1538. PMCID: PMC6341982
8. Huang H, Springborn S, Haug K, Bartow K, Samra H, Menon S, Mackinnon AC. Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine. J Mol Diagn. 2019 09;21(5):862-872.
9. Le-Rademacher JG, Rowland K, Atherton PJ, Dakhil C, Sun Z, Tan A, Schmidt L, Nguyen PL, Radecki Breitkopf C, Pittelkow M, Tindall D, Menon S, Jatoi A. Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series. Am J Hosp Palliat Care. 2019 Jun;36(6):519-525.
 
Books, Chapters, and Reviews
1. Patiyil S, Alberts SR, Metastatic colorectal cancer: Therapeutic options, Curr Treat Options Oncol, 2006 Sep;7(5):389-98.
2. Patiyil S, Chan NS, Jatoi A, New Agents, New Rashes: An Update on Skin Complications from Chemotherapy. Curr Oncol Rep; 2006 Jul;8(4):269-74.
3. Patiyil S, Jatoi A. Tumor Necrosis Factor in the Management of Cancer Associated Weight Loss Syndrome. 1st ed CRC Pr, 2005: 473-487 ISBN 0-8493-3379-2.
 
Non-Refereed Journal Publications/Original Papers
1. Menon S, Habermann T, Witzig T. Lenalidomide associated hypothyroidism. Leuk Lymphoma. 2007 Dec;48(12):2465-7.